Canadian Product Portfolio English Français

Medexus Pharmaceuticals, Inc. Medexus Pharmaceuticals, Inc.

  • English
  • About
    • Overview
    • Growth Strategy
    • Management Team
    • Board of Directors
  • Divisions
    • Overview
    • Medexus Pharma Canada
    • Medexus Pharma USA
  • Product Portfolio
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Media
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Results
    • Stock Data
    • Governance
    • SEDAR
  • Contact
  • Careers
  • English
  • Français
  • Canadian Product Portfolio

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
  • Media
Apr 22, 2022 8:30am EDT

Medexus Pharmaceuticals Announces Resubmission of Treosulfan NDA

Apr 19, 2022 4:20pm EDT

Medexus to Present at the Bloom Burton & Co. Healthcare Investor Conference

Mar 09, 2022 8:00am EST

Medexus to Participate in the 34th Annual Roth Conference

Mar 01, 2022 7:15am EST

Medexus Pharmaceuticals Announces Deal for Gleolan in the United States

Feb 14, 2022 8:00am EST

Medexus Pharmaceuticals Announces Normal Course Issuer Bid, or NCIB, for Convertible Debentures

Feb 09, 2022 6:30pm EST

Medexus Pharmaceuticals Generated $21.3M in Fiscal 2022 Third Quarter Revenues and Achieved $1.9M Positive EBITDA for the Three Months Ended December 31, 2021

Feb 01, 2022 4:15pm EST

Medexus to Present at The MicroCap Rodeo’s 2nd Annual Winter Wonderland Best Ideas Investor Conference

Jan 31, 2022 8:00am EST

Medexus Schedules Third Quarter Fiscal 2022 Conference Call

Jan 07, 2022 9:00am EST

Medexus to Present at the H.C. Wainwright BioConnect 2022 Conference

Dec 02, 2021 4:15pm EST

Medexus to Participate in Two Upcoming Virtual Investor Conferences

RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...11
Next
© 2022 Medexus Pharmaceuticals, Inc.
All Rights Reserved.
Facebook Facebook
Privacy Policy Disclaimer Sitemap

Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.